YOU ARE HERE:
Latin America news
page  of 5
 
Headline
Date
  Brazil issues compulsory license on efavirenz
07.05.07
  Brazil demands 60% efavirenz price cut, or may break patent
26.04.07
  Leprosy reported after starting HIV treatment, but it isn't a serious public health concern
08.02.07
  Non UK-born migrants are 'largely hidden' from NHS and have high burden of HIV, TB and malaria
16.11.06
  Brazil begins negotiations over Kaletra price again
07.11.06
  New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis
03.11.06
  Fast, accurate and easy TB test developed, but concerns about its safety raised
12.10.06
  Alphabet of prevention technologies expanding, but no 'magical solution'
23.08.06
  Lowered AZT dose for low weight patients 'effective and reduces toxicity'
10.08.06
  Drop d4T from first-line therapy, WHO advises low-income countries – if you can afford to
08.08.06
  Lipodystrophy study halted after patient death
31.07.06
  Guide to international entry restrictions for people with HIV published
27.07.06
  Kaletra receives EU marketing approval; developing countries registration 'moving forward'
04.07.06
  Fees for HIV treatment increase risk of death in developing countries
16.06.06
  Four more Ranbaxy drugs on WHO pre-qualification list
05.06.06
  MSF study says 3TC/d4T/NVP fixed-dose combination should be provided 'rapidly and without reservation' in resource-limited countries
29.05.06
  US anti-prostitution gag for HIV work unconstitutional, rules US judge (corrected)
12.05.06
  Model reveals benefits of treatment on number of HIV infections and deaths from AIDS in resource-limited settings
12.05.06
  Final report on 3 by 5 - target not met, but progress and valuable lessons for universal access by 2010
28.03.06
  Merck announces 20% cut in efavirenz price for low and middle-income countries
07.03.06

page  of 5